Search for: "Janssen Pharmaceuticals Inc." Results 61 - 80 of 195
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
17 Dec 2015, 5:50 pm by Sean Wajert
Ortho-McNeil-Janssen Pharmaceuticals Inc., No. 15-3104, 2015 WL 8538119 (6th Cir. [read post]
10 Dec 2015, 8:00 pm by John Ehrett
The petition of the day is: Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
23 Nov 2015, 8:00 am by Robert Kreisman
Janssen Pharmaceuticals Inc., Johnson & Johnson Company and Johnson Pharmaceutical Research and Development, LLC, No. 130401990, Philadelphia County, Court of Common Pleas (Nov. 11, 2015). [read post]
17 Nov 2015, 5:07 am by Grimes Teich Anderson LLP
Recent articles in Forbes Magazine and The Wall Street Journal reported that Janssen Pharmaceuticals, Inc., which is a Johnson & Johnson company, has been accused of a failure to warn about the side effect. [read post]
10 Nov 2015, 11:33 am by Tom Lamb
"] The findings are contrary to data presented [in "New Global Real-World Data from Atrial Fibrillation Studies Confirm the Safety Profile of XARELTO®", a press release from Janssen Pharmaceuticals, Inc.] on the safety of [Xarelto (rivaroxaban)] in 39,052 people with NVAF showed the rates and patterns of major bleeding in routine clinical practice were 2.89 per 100 person-years. [read post]
9 Nov 2015, 7:39 am
Merck Sharp & Dohme v Ono Pharmaceutical [2015] EWHC 2973 (Pat), decided on 22 October by Mr Justice Birss in the Patents Court, England and Wales, is a decidedly unbifurcated ruling, being a full-blooded infringement-and-invalidity action running to 243 paragraphs. [read post]
1 Nov 2015, 9:57 pm by Patent Docs
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
12 Oct 2015, 8:35 am by Gregory J. Brod
Marketing of Risperdal One portion of the settlement involves criminal allegations that sales personnel at Janssen Pharmaceuticals Inc. promoted Risperdal for use in elderly dementia patients, a use not approved by the FDA. [read post]
29 Sep 2015, 4:45 am by briadm
The plaintiff, Sonja Lemoins, filed the 90-count complaint in Madison County, Illinois, against Janssen Pharmaceuticals, Inc., Bayer Corporation and several related companies. [read post]
8 Sep 2015, 1:15 pm by Tom Lamb
Given these numerous case reports made to Health Canada and documented in medical articles, one wonders whether the responsible drug company, Janssen Pharmaceuticals, Inc., should increase the drug label warnings about hepatic / liver side effects such as acute liver failure, which can be fatal in some instances. [read post]
21 Jun 2015, 6:17 pm by Ed. Puerto Rico
Por estas razones, se desestimaron las causas de acción y de igual manera las causas de acción bajo las leyes locales contra Johnson & Johnson Services, Inc., Janssen Cilag Mfg., LLC; Janssen Ortho, LLC. [read post]